GFAP and early-onset autosomal dominant Alzheimer disease: Given that plasma GFAP and NfL are elevated not only in FTD but also in other neurological diseases such as Alzheimer disease [7], stroke [50, 51], and TBI [6], these biomarkers are not anticipated to serve as FTD-specific diagnostic markers.